Predictors of viral pneumonia in patients with community-acquired pneumonia

PLoS ONE

Volumn 9, Issue 12, 2014, Pages

  Kim, Ji Eun ^a   Kim, Uh Jin ^a   Kim, Hee Kyung ^a   Cho, Soo Kyung ^a   An, Joon Hwan ^a   Kang, Seung Ji ^a   Park, Kyung Hwa ^a   Jung, Sook In ^a   Jang, Hee Chang ^a  

^a Chonnam National University Medical School   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; OSELTAMIVIR; PERAMIVIR; VIRUS DNA; VIRUS RNA;

ADULT; AGED; ARTICLE; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEMOGRAPHY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE MARKER; EARLY INTERVENTION; ELECTRONIC MEDICAL RECORD; FEMALE; GROUND GLASS OPACITY; HOSPITAL INFORMATION SYSTEM; HUMAN; HUMAN CELL; INFECTION RISK; LABORATORY TEST; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEDICAL PARAMETERS; NONHUMAN; POLYMERASE CHAIN REACTION; PREDICTION; PREDICTIVE VALUE; RADIOLOGICAL PARAMETERS; RESPIRATORY VIRUS; RETROSPECTIVE STUDY; RHINORRHEA; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY AND SPECIFICITY; TEACHING HOSPITAL; VIRUS PNEUMONIA; ADENOVIRIDAE; AREA UNDER THE CURVE; BLOOD; CEREBROSPINAL FLUID RHINORRHEA; COMMUNITY-ACQUIRED INFECTIONS; COMPLICATION; CYTOLOGY; GENETICS; LEUKOCYTE; MIDDLE AGED; ODDS RATIO; ORTHOMYXOVIRIDAE; PNEUMONIA, VIRAL; RADIOGRAPHY; RECEIVER OPERATING CHARACTERISTIC; STATISTICAL MODEL; VERY ELDERLY; VIROLOGY;

NUCLEOPOLYHEDROVIRUS;

ADENOVIRIDAE; AGED; AGED, 80 AND OVER; AREA UNDER CURVE; CEREBROSPINAL FLUID RHINORRHEA; COMMUNITY-ACQUIRED INFECTIONS; CREATININE; DNA, VIRAL; FEMALE; HUMANS; LEUKOCYTES; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; ORTHOMYXOVIRIDAE; PNEUMONIA, VIRAL; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE OF TESTS; RNA, VIRAL; ROC CURVE;

EID: 84919632279     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0114710     Document Type: Article

References (38)

1. Guthrie R (2001) Community-acquired lower respiratory tract infections: etiology and treatment. Chest 120: 2021-2034.
2. File TM (2003) Community-acquired pneumonia. Lancet 362: 1991-2001.
3. Templeton KE, Scheltinga SA, van den Eeden WC, Graffelman AW, van den Broek PJ, et al. (2005) Improved diagnosis of the etiology of community-acquired pneumonia with real-time polymerase chain reaction. Clin Infect Dis 41: 345-351.
4. Jennings LC, Anderson TP, Beynon KA, Chua A, Laing RT, et al. (2008) Incidence and characteristics of viral community-acquired pneumonia in adults. Thorax 63: 42-48.
5. Zhou W, Lin F, Teng L, Li H, Hou J, et al. (2013) Prevalence of herpes and respiratory viruses in induced sputum among hospitalized children with non typical bacterial community-acquired pneumonia. PLoS One 8: e79477.
6. Sandrock CE (2008) Severe febrile respiratory illnesses as a cause of mass critical care. Respir Care 53: 40-53; discussion 53-47.
7. Ruuskanen O, Lahti E, Jennings LC, Murdoch DR (2011) Viral pneumonia. Lancet 377: 1264-1275.
8. Hong HL, Hong SB, Ko GB, Huh JW, Sung H, et al. (2014) Viral infection is not uncommon in adult patients with severe hospital-acquired pneumonia. PLoS One 9: e95865.
9. Choi SH, Hong SB, Ko GB, Lee Y, Park HJ, et al. (2012) Viral infection in patients with severe pneumonia requiring intensive care unit admission. Am J Respir Crit Care Med 186: 325-332.
10. Pavia AT (2013) What is the role of respiratory viruses in community-acquired pneumonia?: What is the best therapy for influenza and other viral causes of community-acquired pneumonia? Infect Dis Clin North Am 27: 157-175.
11. An JH, Kim HN, Choi OJ, Kim GS, Kim UJ, et al. (2013) Was 2009 Pandemic Influenza A (H1N1) Mild Among Pregnant Korean Women? Chonnam Med J 49: 96-99.
12. Ison MG (2013) Clinical use of approved influenza antivirals: therapy and prophylaxis. Influenza Other Respir Viruses 7 Suppl 1: 7-13.
13. McGeer A, Green KA, Plevneshi A, Shigayeva A, Siddiqi N, et al. (2007) Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada. Clin Infect Dis 45: 1568-1575.
14. Sandrock C, Stollenwerk N (2008) Acute febrile respiratory illness in the ICU: reducing disease transmission. Chest 133: 1221-1231.
15. Hong SD, Park SH, Kang SJ, Kwon YS, Kee SJ, et al. (2011) First Fatal Oseltamivir-Resistant 2009 Pandemic Influenza A (H1N1) Case in an Adult in Korea. Chonnam Med J 47: 127-129.
16. Kang SJ, Park KH, Kee SJ, Shin JH, Jung SI, et al. (2013) Virological clearance rate of high-dose oseltamivir or triple-combination antiviral therapy in complicated 2009 pandemic influenza A (H1N1) infection. Jpn J Infect Dis 66: 425-427.
17. Gueller S, Duenzinger U, Wolf T, Ajib S, Mousset S, et al. (2013) Successful systemic high-dose ribavirin treatment of respiratory syncytial virus-induced infections occurring pre-engraftment in allogeneic hematopoietic stem cell transplant recipients. Transpl Infect Dis 15: 435-440.
18. Jefferson T, Jones MA, Doshi P, Del Mar CB, Hama R, et al. (2014) Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children. Cochrane Database Syst Rev 4: CD008965.
19. Leibovici L, Paul M (2014) Should we recommend neuroaminidase inhibitors for influenza? Clin Microbiol Infect.
20. Higuera Iglesias AL, Kudo K, Manabe T, Corcho Berdugo AE, Corrales Baeza A, et al. (2011) Reducing occurrence and severity of pneumonia due to pandemic H1N1 2009 by early oseltamivir administration: a retrospective study in Mexico. PLoS One 6: e21838.
21. Lee N, Choi KW, Chan PK, Hui DS, Lui GC, et al. (2010) Outcomes of adults hospitalised with severe influenza. Thorax 65: 510-515.
22. Muthuri SG, Venkatesan S, Myles PR, Leonardi-Bee J, Al Khuwaitir TS, et al. (2014) Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data. Lancet Respir Med 2: 395-404.
23. Laskowski M, Greer AL, Moghadas SM (2014) Antiviral strategies for emerging influenza viruses in remote communities. PLoS One 9: e89651.
24. Musher DM, Roig IL, Cazares G, Stager CE, Logan N, et al. (2013) Can an etiologic agent be identified in adults who are hospitalized for community-acquired pneumonia: results of a one-year study. J Infect 67: 11-18.
25. Huijskens EG, Koopmans M, Palmen FM, van Erkel AJ, Mulder PG, et al. (2014) The value of signs and symptoms in differentiating between bacterial, viral and mixed aetiology in patients with communityacquired pneumonia. J Med Microbiol 63: 441-452.
26. Sangil A, Calbo E, Robles A, Benet S, Viladot ME, et al. (2012) Aetiology of community-acquired pneumonia among adults in an H1N1 pandemic year: the role of respiratory viruses. Eur J Clin Microbiol Infect Dis 31: 2765-2772.
27. You JH, Chan ES, Leung MY, Ip M, Lee NL (2012) A cost-effectiveness analysis of "test" versus "treat" patients hospitalized with suspected influenza in Hong Kong. PLoS One 7: e33123.
28. Singanayagam A, Chalmers JD (2013) Severity assessment scores to guide empirical use of antibiotics in community acquired pneumonia. Lancet Respir Med 1: 653-662.
29. Kim HK, Oh SH, Yun KA, Sung H, Kim MN (2013) Comparison of Anyplex II RV16 with the xTAG respiratory viral panel and Seeplex RV15 for detection of respiratory viruses. J Clin Microbiol 51: 1137-1141.
30. Cesario TC (2012) Viruses associated with pneumonia in adults. Clin Infect Dis 55: 107-113.
31. Jacobs SE, Lamson DM, St George K, Walsh TJ (2013) Human rhinoviruses. Clin Microbiol Rev 26: 135-162.
32. Johansson N, Kalin M, Tiveljung-Lindell A, Giske CG, Hedlund J (2010) Etiology of communityacquired pneumonia: increased microbiological yield with new diagnostic methods. Clin Infect Dis 50: 202-209.
33. Kim EA, Lee KS, Primack SL, Yoon HK, Byun HS, et al. (2002) Viral pneumonias in adults: radiologic and pathologic findings. Radiographics 22 Spec No: S137-149.
34. Zhang Q, Zhao ZW, Xing ZL, Zhang B, Zheng HF, et al. (2013) Analysis of the risk factors for influenza A (H1N1) pneumonia. Biomed Rep 1: 723-726.
35. Albrich WC, Dusemund F, Bucher B, Meyer S, Thomann R, et al. (2012) Effectiveness and safety of procalcitonin-guided antibiotic therapy in lower respiratory tract infections in "real life": an international, multicenter poststudy survey (ProREAL). Arch Intern Med 172: 715-722.
36. Franquet T (2011) Imaging of pulmonary viral pneumonia. Radiology 260: 18-39.
37. Miller WT Jr, Mickus TJ, Barbosa E Jr, Mullin C, Van Deerlin VM, et al. (2011) CT of viral lower respiratory tract infections in adults: comparison among viral organisms and between viral and bacterial infections. AJR Am J Roentgenol 197: 1088-1095.
38. Shiley KT, Van Deerlin VM, Miller WT Jr (2010) Chest CT features of community-acquired respiratory viral infections in adult inpatients with lower respiratory tract infections. J Thorac Imaging 25: 68-75.